期刊
CARDIOVASCULAR RESEARCH
卷 115, 期 8, 页码 1266-1285出版社
OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvz084
关键词
Neutrophils; Microvesicles; NETs; Myocardial infarction; Heart failure; Stroke
资金
- Rete Cardiologica of the Italian Ministry of Health
- Swiss National Science Foundation [310030_175546]
- Swiss Heart Foundation
- Alfred and Annemarie von Sick Grants for Translational and Clinical Research Cardiology and Oncology
- Foundation for Cardiovascular Research-Zurich Heart House
- Sheikh Khalifa's Foundation Ass. Professorship at the Faculty of Medicine, University of Zurich
- Swiss National Science Foundation (SNF) [310030_175546] Funding Source: Swiss National Science Foundation (SNF)
Neutrophils are the most abundant circulating leucocytes in healthy humans. These cells are central players during acute inflammatory responses, although a growing body of evidence supports a crucial role in chronic inflammation and chemokines and cytokines related to it as well. Thus, both humoral and cellular components are involved in the development of plaque formation and atherosclerosis. Accordingly, CANTOS trial using an interleukin-1 beta antibody confirmed that inflammatory cytokines contribute to the occurrence of myocardial infarction and cardiac death independent of changes in lipids. Recent data revealed that neutrophils are a heterogeneous population with different subsets and functional characteristics (i.e. CD177(+) cells, OLFM4(+) neutrophils, proangiogenic neutrophils, neutrophils undergoing reverse migration, and aged neutrophils). Importantly, neutrophils are able to synthesize de novo proteins. Neutrophil extracellular trap generation and NETosis have been considered as very important weapons in sterile inflammation. Neutrophil-derived microvesicles represent another mechanism by which neutrophils amplify inflammatory processes, being found at high levels both at the site of injury and in the bloodstream. Finally, neutrophil aging can influence their functions also in relation with host age. These recent acquisitions in the field of neutrophil biology might pave the way for new therapeutic targets to prevent or even treat patients experiencing cardiovascular (CV) diseases. Here, we discuss novel findings in neutrophil biology, their impact on CV and cerebrovascular diseases, and the potential implementation of these notions into daily clinical practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据